Talk:COVID-19 Genomics UK Consortium

COVID-19 Mid‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

United Kingdom Low‑importance

	United Kingdom portal This article is within the scope of WikiProject United Kingdom, a collaborative effort to improve the coverage of the United Kingdom on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.United KingdomWikipedia:WikiProject United KingdomTemplate:WikiProject United KingdomUnited Kingdom articles
Low	This article has been rated as Low-importance on the project's importance scale.

"administered by UKRI" is not backed/supported by the given source

The bottom line of the source name=":1" https://www.cogconsortium.uk/uk-launches-whole-genome-sequence-alliance-to-map-spread-of-coronavirus/ says that UKRI funded COG-UK, but the source does not back/support the information that UKRI administers COG-UK. --Himbeerbläuling (talk) 15:00, 18 April 2021 (UTC)[reply]

Agreed, @Himbeerbläuling. The source does not mention administration of funding, and after checking several independent sources that discuss the funding, I was unable to find any that confirm who administered the finances. So, I removed the unsourced statement. - AppleBsTime (talk) 01:13, 17 February 2023 (UTC)[reply]

Strategic purposes

Which advantage do COG-UK aim to achieve for us by their actions?

Somehow obviously, they want to know new variants of concern as early as possible, in order to start the non-pharma parts of the fight (i.e. lockdown, ...) against them as early as possible.
a little less obvious, their goal is to know immuno-escape-mutations as early as possible in order to readjust vaccines (and maybe monoclon. antibodies) as early as possible.
even less obvious: If you know a person 1 who was C19-positive first, and a person 2 who became C19-positive afterwards, you might question whether the first person could have infected the second one. The (partial) answer is: This is possible only if the viruses in person 1 and in person 2 are suffienctly similar, otherwise the question can be surely answered in the negative. This is well-sourced, as the reference name="jacqui-wise" cites Sharon Peacock saying “Mutations are expected and are a natural part of evolution. Many thousands of mutations have already arisen, and the vast majority have no effect on the virus but can be useful as a barcode to monitor outbreaks.”

--Himbeerbläuling (talk) 17:52, 18 April 2021 (UTC)[reply]